Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul D Miller

Bone

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Bone|January 15, 2011
The kidney and bisphosphonatesPaul D Miller
Bone|June 8, 2017
The history of bone densitometryPaul D Miller
Bone|September 28, 2011
Effects of intravenous ibandronate injection on renal function in women with postmenopausal osteoporosis at high risk for renal disease--the DIVINE studyPaul D Miller, Sergio Ragi-Eis, Carlos Mautalen, et al.
Bone|October 28, 2008
Efficacy and safety of monthly oral ibandronate in the prevention of postmenopausal bone lossMichael R McClung, Michael A Bolognese, Farhad Sedarati, et al.
Bone|June 10, 2008
Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: a randomized blinded phase 2 clinical trialPaul D Miller, Michael A Bolognese, E Michael Lewiecki, et al.
Bone|January 9, 2020
History of etidronateNelson B Watts, Charles H Chesnut, Harry K Genant, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Bone|January 15, 2011
The kidney and bisphosphonatesPaul D Miller
Bone|June 8, 2017
The history of bone densitometryPaul D Miller
Bone|September 28, 2011
Effects of intravenous ibandronate injection on renal function in women with postmenopausal osteoporosis at high risk for renal disease--the DIVINE studyPaul D Miller, Sergio Ragi-Eis, Carlos Mautalen, et al.
Bone|October 28, 2008
Efficacy and safety of monthly oral ibandronate in the prevention of postmenopausal bone lossMichael R McClung, Michael A Bolognese, Farhad Sedarati, et al.
Bone|June 10, 2008
Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: a randomized blinded phase 2 clinical trialPaul D Miller, Michael A Bolognese, E Michael Lewiecki, et al.
Bone|January 9, 2020
History of etidronateNelson B Watts, Charles H Chesnut, Harry K Genant, et al.
Pageof 1